Methods, systems, and devices for integrated photo-responsive contouring treatment are described. Methods include identifying a region of skin corresponding to a contouring treatment of the skin. The region of skin may be provided with a photo-responsive material overlying a portion of the region of the skin. Methods may include identifying one or more treatment regions overlapping the photo-responsive material. The treatment regions may be identified at least in part to apply the contouring treatment. Methods may include determining an irradiation profile for each of the one or more treatment regions to contour each respective treatment region as part of applying the contouring treatment. Methods may also include irradiating the photo-responsive material at the one or more treatment regions in accordance with the respective irradiation profiles. Irradiating the photo-responsive material may induce a localized change in shape of the photo-responsive material in the respective treatment regions.

A catheter is disclosed for performing ultraviolet light therapy in a pulmonary system of a patient, which includes a catheter body having opposed proximal and distal end portions, a handle assembly operatively associated with the proximal end portion of the catheter body, an illumination assembly operatively associated with the distal end portion of the catheter body and including an LED light source for generating UVC radiation, wherein the illumination assembly includes a coupler connecting the LED light source with the distal end portion of the catheter body, and an elongated braided sleeve disposed within the catheter body, wherein the coupler is adapted to transfer heat from the illumination assembly to the braided sleeve, such that the braided sleeve serves as a heat sink for the illumination assembly.

A method is provided for performing electromagnetic radiation therapy on a subject. The method comprises providing a device which emits electromagnetic radiation, wherein the electromagnetic radiation includes a first portion that oscillates between at least first and second distinct states, and a second non-oscillatory portion; and illuminating the subject with the electromagnetic radiation.

The present invention is directed to systems and methods for thermal therapy, especially to detection-guided, -controlled, and temperature-modulated interstitial thermal therapy. Thermal therapy may be used to treat the tissues of a patient. In the case of interstitial thermal therapy, energy is applied to generate heating of the tissue to affect treatment, such as, for example, thermally inducing tissue damage (e.g. thermally-induced tissue necrosis), which may be useful in treating tumors and/or other diseased tissues. Since targets for thermal therapy are internal to the patient, the use of detection guidance may be useful in locating and monitoring treatment of a target tissue.

Systems, methods, and devices used to treat eyelids, meibomian glands, ducts, and surrounding tissue are described herein. In some embodiments, an eye treatment device is disclosed, which includes a scleral shield positionable proximate an inner surface of an eyelid, the scleral shield being made of, or coated with, an energy-absorbing material activated by a light energy, and an energy transducer positionable outside of the eyelid, the energy transducer configured to provide light energy at one or more wavelengths, including a first wavelength selected to heat the energy-absorbing material. Wherein, when the eyelid is positioned between the energy transducer and the scleral shield, the light energy from the energy transducer and the heated energy-absorbing material of the scleral shield conductively heats a target tissue region sufficiently to melt meibum within meibomian glands located within or adjacent to the target tissue region.

Modulation of neural activity in the superior laryngeal nerve (SLN) or cervical sympathetic trunk (CST) is effective in treating diseases and conditions mediated by thyroid and parathyroid hormones, in particular diseases associated with calcitonin secretion (e.g. osteoporosis) or diseases associated with thyroxine secretion (e.g. hypothyroid syndrome).

An object of the present invention is to provide a chair-type phototherapy device that enables a patient to perform light irradiation accurately targeted at a treatment site in a seated position on a chair and consequently achieves effective phototherapy even when the treatment site is in the back region that the patient is unable to see, for example, as in light irradiation for dysuria patients and patients with pain, and the patient performs light irradiation by himself/herself at home. The present invention provides a chair-type phototherapy device having a seat on which a patient is seated. The chair-type phototherapy device includes a radiation module configured to emit radiation light toward a living body, a drive module positioned behind the patient for moving the radiation module, and a fixing module fixing the drive module to the seat.

A balloon catheter comprising: a first shaft having a first lumen and a second lumen; a second shaft located distal to the first shaft; a balloon located distal to the second shaft; and a tubular member that is disposed inside the balloon and has a light transmittance of 90% or more; wherein: the first shaft is made of a resin; a cross-sectional area of the resin forming the first shaft is larger than a cross-sectional area of either the first lumen or the second lumen, which has a larger cross-sectional area, in a cross section perpendicular to a longitudinal direction; a proximal end of the tubular member is joined to a distal end of the first lumen; a proximal end of the balloon is joined to the second shaft; and a distal end of the balloon is joined to the tubular member.

A method and system for of treating type 1 includes implanting genetically modified islet cells under a capsule of or within an organ, implanting a microsystem adjacent the islet cells, said microsystem, comprising a light emitting diode stimulator comprising a plurality of light emitting diodes, determining a glucose level in a body and controlling the microsystem to selectively illuminate the islet cells to secrete insulin or glucagon or both based on the glucose level.

The present invention discloses a terahertz material with therapeutic and health care effect and its preparation method and application, which includes the following raw materials in parts by weight: 15˜28 SiO.sub.2, 3˜8 Al.sub.2O.sub.3, 1˜3 selenium, 2˜5 germanium, 10˜15 Fe.sub.2O.sub.3, 35˜45 ochre, 20˜35 zinc oxide, 65˜80 CaCO.sub.3, 0.1˜0.5 rare earth palladium, 1˜10 SiO.sub.x, wherein the raw materials of components are mixed according to the above proportion, and crushing, heating to 600˜1200° C. in an oxygen free environment for 3˜8 hours, and then secondary crushing, having a fineness of 3000˜8000 mesh; and then, after crushing again and powdering processing, the fineness reaches more than 10000 mesh. After being enhanced treatment by the terahertz irradiation line, the terahertz materials with therapeutic and health care effects are obtained. They can be processed and manufactured into a variety of physiotherapy equipment, with fast action speed and stable effect on human body.